IL13 and Alzheimer disease: For example, skin from AD patients is characterized by overexpression of the type 2 cytokines IL-4 and IL-13 and, conversely, production of type 1 cytokines IL-12 and IFN-γ is reduced, which in turns reduce the expression of the human cathelicidin LL-37 [224].